";s:4:"text";s:6517:"It may harm them.This Medication Guide summarizes the most important information about Paxil.
There is not sufficient evidence to suggest a greater benefit to doses higher than 20 mg/day. Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Mean digoxin AUC at steady state decreased by 15% in the presence of paroxetine. If it is near the time of the next dose, skip the missed dose. Do not use Paxil for a condition for which it was not prescribed. Therapy with Paxil may be resumed 24 hours after the last dose of linezolid or intravenous methylene blue (see The risk of administering methylene blue by non-intravenous routes (such as oral tablets or by local injection) or in intravenous doses much lower than 1 mg/kg with Paxil is unclear. Unless the benefits of paroxetine to the mother justify continuing treatment, consideration should be given to either discontinuing paroxetine therapy or switching to another antidepressant (see Reproduction studies were performed at doses up to 50 mg/kg/day in rats and 6 mg/kg/day in rabbits administered during organogenesis. Panic disorder is characterized by the occurrence of unexpected panic attacks and associated concern about having additional attacks, worry about the implications or consequences of the attacks, and/or a significant change in behavior related to the attacks.The efficacy of Paxil was established in three 10- to 12‑week trials in panic disorder patients whose diagnoses corresponded to the DSM‑IIIR category of panic disorder (see Panic disorder (DSM‑IV) is characterized by recurrent unexpected panic attacks, i.e., a discrete period of intense fear or discomfort in which 4 (or more) of the following symptoms develop abruptly and reach a peak within 10 minutes: (1) palpitations, pounding heart, or accelerated heart rate; (2) sweating; (3) trembling or shaking; (4) sensations of shortness of breath or smothering; (5) feeling of choking; (6) chest pain or discomfort; (7) nausea or abdominal distress; (8) feeling dizzy, unsteady, lightheaded, or faint; (9) derealization (feelings of unreality) or depersonalization (being detached from oneself); (10) fear of losing control; (11) fear of dying; (12) paresthesias (numbness or tingling sensations); (13) chills or hot flushes.Long‑term maintenance of efficacy was demonstrated in a 3‑month relapse prevention trial. However, due to the potential for serotonin syndrome, caution is advised when Paxil is coadministered with lithium.The steady‑state pharmacokinetics of paroxetine was not altered when administered with digoxin at steady state. All reports with methylene blue that provided information on the route of administration involved intravenous administration in the dose range of 1 mg/kg to 8 mg/kg. It should be noted that Paxil is not approved for use in treating bipolar depression.The development of a potentially life-threatening serotonin syndrome has been reported with SNRIs and SSRIs, including Paxil, alone but particularly with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea). To compare the effects of paroxetine on the pharmacokinetics and pharmacodynamics of the immediate‐release (IR) and extended‐release (ER) formulations of metoprolol. The best pharmacy shop on the Web.
The percentage of patients with secondary major depressive disorder or non-PTSD anxiety disorders in the combined 2 studies was 41% (356 out of 858 patients) and 40% (345 out of 858 patients), respectively.
In many cases, this hyponatremia appears to be the result of the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Patients were dosed in a range of 20 to 60 mg/day in the clinical trials demonstrating the effectiveness of Paxil in the treatment of OCD. In this trial, patients with OCD assigned to paroxetine demonstrated a lower relapse rate compared to patients on placebo (see Paxil should be administered as a single daily dose with or without food, usually in the morning. Get medical help right away if you have any of these symptomsWhat should I tell my healthcare provider before taking Paxil? Patients who were responders during the 10‑week double‑blind phase and during a 3‑month double‑blind extension phase were randomized to either paroxetine (10, 20, or 40 mg/day) or placebo in a 3‑month double‑blind relapse prevention phase. A third study, also flexible-dose comparing paroxetine (20 mg to 50 mg daily), did not demonstrate statistically significant superiority of Paxil over placebo on the Hamilton Rating Scale for Anxiety (HAM‑A) total score, the primary outcome.Subgroup analyses did not indicate differences in treatment outcomes as a function of race or gender.